Clinical Trials Arena on MSN21 小时
FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes
Last July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the ...
Helsinki4 年
The FINNMODY study
Glucokinase-MODY and HNF1A-MODY are the two most common subtypes of MODY. A mild subtype of MODY, glucokinase-MODY, might remain undiagnosed for decades, as the symptoms are generally mild or ...
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
Irish Star on MSN4 个月
Two key superfoods lower blood sugar without needing insulin, experts say
Magnesium regulates an enzyme known as glucokinase, responsible for converting glucose into glucose-6-phosphate. Type 2 ...